temozolomide has been researched along with Proteinuria in 3 studies
Proteinuria: The presence of proteins in the urine, an indicator of KIDNEY DISEASES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We evaluated clinical and survival data of glioblastoma patients who underwent treatment with bevacizumab after progression under temozolomide, at CHUSJ between 2010 and 2017." | 3.96 | Hypertension and proteinuria as clinical biomarkers of response to bevacizumab in glioblastoma patients. ( Caeiro, C; Carvalho, B; Costa, A; Fernandes, AC; Linhares, P; Lopes, RG; Osório, L; Tavares, N; Vaz, R, 2020) |
| "Glioblastomas are rich in blood vessels (i." | 2.58 | Anti-angiogenic therapy for high-grade glioma. ( Ameratunga, M; Grant, R; Khasraw, M; Pavlakis, N; Simes, J; Wheeler, H, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Carvalho, B | 1 |
| Lopes, RG | 1 |
| Linhares, P | 1 |
| Costa, A | 1 |
| Caeiro, C | 1 |
| Fernandes, AC | 1 |
| Tavares, N | 1 |
| Osório, L | 1 |
| Vaz, R | 1 |
| Ameratunga, M | 1 |
| Pavlakis, N | 2 |
| Wheeler, H | 2 |
| Grant, R | 2 |
| Simes, J | 1 |
| Khasraw, M | 2 |
| Ameratunga, MS | 1 |
2 reviews available for temozolomide and Proteinuria
| Article | Year |
|---|---|
Anti-angiogenic therapy for high-grade glioma.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Brai | 2018 |
Antiangiogenic therapy for high-grade glioma.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Brai | 2014 |
1 other study available for temozolomide and Proteinuria
| Article | Year |
|---|---|
Hypertension and proteinuria as clinical biomarkers of response to bevacizumab in glioblastoma patients.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Immu | 2020 |